The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics
Author:
Publisher
Elsevier BV
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference27 articles.
1. Do cost-effectiveness analyses account for drug genericization? A literature review and assessment of implications;Neumann;Value Health,2022
2. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018;Hernandez;JAMA,2020
3. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine;Sanders;JAMA,2016
4. Cancer drugs: an international comparison of postlicensing price inflation;Savage;J Oncol Pract,2017
5. Why France spends less than the United States on drugs: a comparative study of drug pricing and pricing regulation;Raimond;Milbank Q,2021
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges of Incorporating Life Cycle Drug Pricing in Cost-Effectiveness Models: A Review of Methods and Modeling Suggestions;Value in Health;2024-07
2. Drug Pricing Throughout the Product Lifecycle: A Work in Progress;Value in Health;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3